false 0000101538 UNITED STATES ANTIMONY CORPORATION 0000101538 2026-03-06 2026-03-06 0000101538 UAMY:CommonStockOneMember 2026-03-06 2026-03-06 0000101538 UAMY:CommonStockTwoMember 2026-03-06 2026-03-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported) March 6, 2026

 

  UNITED STATES ANTIMONY CORPORATION  
  (Exact name of registrant as specified in its charter)  

 

Texas   001-08675   81-0305822

(State or other jurisdiction

of incorporation) 

 

(Commission

File No.)

 

(IRS Employer

Identification Number)

 

4438 W. Lovers Lane, Unit 100, Dallas, TX   75209
(Address of principal executive officers)   (Zip Code)

 

Registrant’s telephone number, including area code: (406) 606-4117

 

Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Common Stock, $0.01 par value   UAMY   NYSE American
Common Stock, $0.01 par value   UAMY   NYSE Texas

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

 

On March 6, 2026, United States Antimony Corporation (NYSE: UAMY) (NYSE Texas: UAMY) (“USAC,” “US Antimony,” or the “Company”) announced New York Stock Exchange (the “NYSE”) had approved the uplisting of the Company’s common stock, par value $0.01 per share, from the NYSE American LLC (the “NYSE American”) to the NYSE (the “Transfer”), where the common stock will continue to trade under the ticker symbol “UAMY.” The Company expects that trading of its common stock on the NYSE will commence on March 11, 2026. The common stock will continue to trade on the NYSE American under the ticker symbol “UAMY” until the Transfer is complete. The Company will remain listed on the NYSE Texas Exchange under the symbol “UAMY.”

 

Item 7.01 Regulation FD Disclosure

 

On March 6, 2026, the Company issued a press release announcing the Transfer.

 

A copy of the Press Release is attached as Exhibit 99.1 and is hereby incorporated by reference into this Item 7.01. The information contained in this Current Report on Form 8-K, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, except to the extent expressly stated in such filing.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Current Report on Form 8-K, including the Press Release, contains forward-looking statements, including the Company’s plans for, and potential benefit from, the joint venture. Forward-looking statements reflect management's current knowledge, assumptions, judgment, and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct, and you should be aware that actual events or results may differ materially from those contained in the forward- looking statements. Words such as “will,” “expect,” “intend,” “plan,” “potential,” “possible,” “goals,” “accelerate,” “continue,” and similar expressions identify forward-looking statements.

 

Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to, those described in the Company’s filings on Form 10-K, Form 10-Q, and Form 8-K with the United States Securities and Exchange Commission.

 

All forward-looking statements are expressly qualified in their entirety by this cautionary notice. You should not rely upon any forward-looking statements as predictions of future events. The Company undertakes no obligation to revise or update any forward-looking statements made in this Current Report on Form 8-K to reflect events or circumstances after the date hereof, to reflect new information or the occurrence of unanticipated events, to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, in each case, except as required by law.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
No.
  Description
99.1  Press Release issued by United States Antimony Corporation dated March 6, 2026
104  Cover Page Interactive Data File (embedded with the inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  UNITED STATES ANTIMONY CORPORATION
     
Dated: March 6, 2026   By: /s/ Gary C. Evans
  Gary C. Evans
  Chief Executive Officer